Concepedia

Gregory J. Wiederrecht

GJ

Statistics

Publications

8

Citations

1.6K

H-Index

8

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Mayo Clinic

Salk Institute for Biological Studies

Vanderbilt University

Gregory J. Wiederrecht is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, pharmacology, and cell signaling.

Publications per year

1995–1998

8

Publications

8

Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells

Candace J. Sabers, Mary M. Martin, Gregory J. Brunn et al. · Journal of Biological Chemistry · 1995 · 876 citations · Full text

, , +12

A Novel FK506 Binding Protein Can Mediate the Immunosuppressive Effects of FK506 and Is Associated with the Cardiac Ryanodine Receptor

Elsa Lam, Mary M. Martin, A.P. Timerman et al. · Journal of Biological Chemistry · 1995 · 183 citations · Full text

, , +17

Fkbp51, a Novel T-Cell-Specific Immunophilin Capable of Calcineurin Inhibition

Gail Baughman, Gregory J. Wiederrecht, Naomi F. Campbell et al. · Molecular and Cellular Biology · 1995 · 176 citations · Full text

, , +17

Characterization of an Exchange Reaction between Soluble FKBP-12 and the FKBP·Ryanodine Receptor Complex

Gregory J. Wiederrecht, Alice I. Marcy, A.P. Timerman et al. · Journal of Biological Chemistry · 1995 · 144 citations · Full text

, , +17

Tissue Distribution and Abundance of Human FKBP51, an FK506-Binding Protein That Can Mediate Calcineurin Inhibition

Gail Baughman, Gregory J. Wiederrecht, Fon Chang et al. · Biochemical and Biophysical Research Communications · 1997 · 125 citations

, , +7

1–5 of 8